Saturday, 14 May 2022

Reuters Global Healthcare: Sanofi ordered to compensate French family for epilepsy drug side effects

Sanofi ordered to compensate French family for epilepsy drug side effects

A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drugmaker failed to inform about known side effects.

Two more cases of monkeypox infection reported in England

Two more cases of rare viral monkeypox infection have been diagnosed in England, health authorities said on Saturday, adding that they are not linked to one reported a week ago.

North Korea's Kim says COVID 'great turmoil', 21 new deaths reported

North Korean leader Kim Jong Un said on Saturday the spread of COVID-19 had thrust his country into "great turmoil" and called for an all-out battle to overcome the outbreak, as 21 daily deaths were reported among people with fever.

Britain delays ban on promotion of high-sugar foods

Britain will delay by a year new rules banning multi-buy deals on foods and drinks high in fat, salt, or sugar (HFSS), with the government saying on Saturday it needed more time given the cost of living crisis.

Pfizer, EU push back COVID vaccine delivery to help booster campaign

Pfizer Inc and its German partner BioNTech SE said on Friday they had agreed to push back deliveries of their COVID-19 vaccines to the European Union by three months as the bloc prepares for a potential booster campaign in the fall.

U.S. FDA approves Eli Lilly's treatment for type 2 diabetes

The U.S. Food & Drug Administration said on Friday it had approved Eli Lilly's injected drug tirzepatide, which has the brand name Mounjaro, to help improve blood sugar control in adults with type 2 diabetes.

Blood marker identified for babies at risk of SIDS hailed as 'breakthrough'

A team of Australian researchers have identified a biochemical marker in the blood that could help identify newborn babies at risk for sudden infant death syndrome (SIDS), a breakthrough they said creates an avenue to future tragedy-preventing interventions.

COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Japan to offer up to $100 mln in aid to help Indo-Pacific nations fight COVID

Japan plans to extend up to $100 million in aid to developing countries in the Indo-Pacific region to help them better battle the COVID-19 pandemic, Foreign Minister Yoshimasa Hayashi said on Friday.

Abbott says shipped millions of cans of infant formula from Ireland

Abbott Laboratories said on Friday it has air shipped millions of cans of infant formula powder into the United States from its facility in Ireland to address shortages here as it tries to reopen its Michigan manufacturing plant.

Related Videos

After 65 days, American leaves China's lockdown

Moderna asks FDA to authorize COVID shot for kids

FDA pushes ahead to ban menthol cigarettes